 The goal of this clinical research study is to learn the highest tolerable dose of temsirolimus that can be combined with a stable dose of vorinostat andor radiation therapy and given to patients with diffuse intrinsic pontine glioma DIPG. The safety of this treatment combination will also be studied. 